CHINA – Nourish Ingredients, a leader in speciality fats and precision fermentation, has signed a joint commercial agreement with CABIO Biotech, a leading Chinese biotechnology company specializing in microbial fermentation and synthetic biology-based products, in China.
In this landmark cross-continental collaboration, the companies will partner to produce and distribute Nourish Ingredients’ flagship product, Tastilux, unlocking the vast potential of the Chinese market.
Tastilux is a premium specialty ingredient derived from natural sources and produced through fermentation, to provide a meaty flavour, aroma and cooking experience to alternative proteins.
This taste is essential in winning over consumers to the plant-based market by providing a delicious animalic taste.
Under the terms of the agreement, CABIO Biotech will leverage its state-of-the-art facilities and expertise to manufacture Tastilux, ensuring efficient, high-quality production with minimal waste at a global scale.
This manufacturing excellence addresses previous challenges faced by Nourish Ingredients, setting a new standard for product quality and consistency.
This strategic partnership represents a significant commercial opportunity for both companies, unlocking several market avenues in China while setting the stage for potential expansion into other Asian markets.
In terms of market expansion, CABIO will assist Nourish Ingredients by spearheading distribution and sales within the Chinese market, utilising their local knowledge and networks.
Meanwhile, Nourish Ingredients will lead commercial engagement and sales in other global markets, with CABIO providing manufacturing support.
“Our strategic partnership with CABIO Biotech marks a pivotal moment for Nourish Ingredients. By leveraging CABIO’s established expertise, we’re not only derisking our supply chain for expansion but also enhancing our ability to deliver high-quality, innovative food solutions at scale,” said James Petrie, CEO of Nourish Ingredients.
“This collaboration combines our cutting-edge product development with CABIO’s manufacturing excellence and market insights, positioning us to meet the surging global demand for superior food ingredients.”
He explained that the partnership will enable them to efficiently produce top-tier products, opening doors to both the dynamic Chinese market and broader international opportunities.
Jimmy Wang, Vice President of CABIO Biotech, added that this collaboration aligns perfectly with the two companies’ commitment to advancing biotechnology and delivering cutting-edge products.
Industry projections indicated that with China’s total meat consumption reaching nearly 100 million tons annually, even a modest 1% substitution with plant-based alternatives by 2026 would create a market of 1 million tons.
This suggest that this market could surge to a value of 3.5 billion by 2028, underscoring the immense growth potential.
Apart from plant-based meats, this collaboration is well-positioned to tap into various market segments including the rapidly growing ready-made meals and prepared dishes sector, the leisure snacks industry, and the continually evolving spices and condiments market.
Sign up HERE to receive our email newsletters with the latest news and insights from Africa and around the world, and follow us on our WhatsApp channel for updates.
